Member Info for Laura2022

OPG big mover

15p+

Very informative stuff

Thanks

One to watch

Placing 0.135p

And now at 4.5p even more of a bargain

Shares in issue - 400m

Today's Mcap at 6p - around £24m.

Today's NAV - around £168m / 42p/share.

Today's build cost/replacement cost for the plant:

£820k per MW for this class.

414MW - £340m replacement value. 85p/share.

If the ED action leads to changes in management and ownership it would be no bad thing.

In the meantime there'll be uncertainty, hence the discount

What an absolute joke

It's like he's already pre empting the confession that DRC is...as ever..going no where

Does Bell want sympathy and a pat on the back for "trying "!!

We no longer face external opposition, it seems, but even when all parties are playing for the same team, there is still a wraithlike team on the other side of the pitch - Messrs Travel, Traffic, Schedule, and the Delay brothers, Illness and Correction

I filtered him 3 weeks ago

Absolutely talks nonsense and changes his script every day

GB

A smaller company that has higher revenues and where CEO only takes 1/4 of average Aim salary does a similar prostate blood/dosing test

:)

and cashed up, £1.3mln cap and £1mln revs with a USA JV deal for their test being g discussed since summer

Pharmacogenomics is rapidly evolving, blending pharmacology with genomics to create personalized medication. This field is crucial as healthcare shifts towards tailored treatments. It promises to streamline drug development and improve patient care through more precise therapies. The integration of artificial intelligence and big data analytics has accelerated progress, revealing key pharmacogenomics market trends and growth strategies. Let's discuss Exploring the Business of Pharmacogenomics.

Recent industry conferences have highlighted the optimism around these innovations.

Then don't buy

Amazing

Don't miss OPG too

Crazy undervalued after falling 13p to 4p

SysGroup plc (AIM:SYS), the technology partner for delivery and management of cloud, data, and security services to power Artificial Intelligence ("AI") and Machine Learning ("ML") transformation, announces that Heejae Chae, Executive Chairman, has today purchased 150,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 23.0 pence per Ordinary Share.

Following the purchase, Heejae has a beneficial interest in 7,857,575 Ordinary Shares, representing approximately 9.47% of the Company's issued share capital

Rob

It's risen 500% !!

Glad I

Glad u took profits

Money to OPG

OPG

Plutuq

See my posts yesterday :)